These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17268814)

  • 1. Genetic variation in the major mitotic checkpoint genes does not affect familial breast cancer risk.
    Vaclavicek A; Bermejo JL; Wappenschmidt B; Meindl A; Sutter C; Schmutzler RK; Kiechle M; Bugert P; Burwinkel B; Bartram CR; Hemminki K; Försti A
    Breast Cancer Res Treat; 2007 Dec; 106(2):205-13. PubMed ID: 17268814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer risk associated with genotypic polymorphism of the mitotic checkpoint genes: a multigenic study on cancer susceptibility.
    Lo YL; Yu JC; Chen ST; Hsu GC; Mau YC; Yang SL; Wu PE; Shen CY
    Carcinogenesis; 2007 May; 28(5):1079-86. PubMed ID: 17210994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.
    Yuan B; Xu Y; Woo JH; Wang Y; Bae YK; Yoon DS; Wersto RP; Tully E; Wilsbach K; Gabrielson E
    Clin Cancer Res; 2006 Jan; 12(2):405-10. PubMed ID: 16428479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinoma.
    Scintu M; Vitale R; Prencipe M; Gallo AP; Bonghi L; Valori VM; Maiello E; Rinaldi M; Signori E; Rabitti C; Carella M; Dallapiccola B; Altomare V; Fazio VM; Parrella P
    Cancer Lett; 2007 Sep; 254(2):298-307. PubMed ID: 17498870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in genes encoding for polymerase ζ subunits associates with breast cancer risk, tumour characteristics and survival.
    Varadi V; Bevier M; Grzybowska E; Johansson R; Enquist K; Henriksson R; Butkiewicz D; Pamula-Pilat J; Tecza K; Hemminki K; Lenner P; Försti A
    Breast Cancer Res Treat; 2011 Aug; 129(1):235-45. PubMed ID: 21455670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of mitotic checkpoint proteins BUB1B and MAD2L1 in salivary duct carcinomas.
    Ko YH; Roh JH; Son YI; Chung MK; Jang JY; Byun H; Baek CH; Jeong HS
    J Oral Pathol Med; 2010 Apr; 39(4):349-55. PubMed ID: 20040022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional evaluation of missense variations in the human MAD1L1 and MAD2L1 genes and their impact on susceptibility to lung cancer.
    Guo Y; Zhang X; Yang M; Miao X; Shi Y; Yao J; Tan W; Sun T; Zhao D; Yu D; Liu J; Lin D
    J Med Genet; 2010 Sep; 47(9):616-22. PubMed ID: 20516147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in ALCAM and other chromosomal instability genes in breast cancer survival.
    Varadi V; Bevier M; Grzybowska E; Johansson R; Enquist-Olsson K; Henriksson R; Butkiewicz D; Pamula-Pilat J; Tecza K; Hemminki K; Lenner P; Försti A
    Breast Cancer Res Treat; 2012 Jan; 131(1):311-9. PubMed ID: 21935604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in the Janus kinase 2 (JAK)/signal transducer and activator of transcription (STAT) genes: putative association of the STAT gene region with familial breast cancer.
    Vaclavicek A; Bermejo JL; Schmutzler RK; Sutter C; Wappenschmidt B; Meindl A; Kiechle M; Arnold N; Weber BH; Niederacher D; Burwinkel B; Bartram CR; Hemminki K; Försti A
    Endocr Relat Cancer; 2007 Jun; 14(2):267-77. PubMed ID: 17639043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline mutations in the spindle assembly checkpoint genes BUB1 and BUB3 are risk factors for colorectal cancer.
    de Voer RM; Geurts van Kessel A; Weren RD; Ligtenberg MJ; Smeets D; Fu L; Vreede L; Kamping EJ; Verwiel ET; Hahn MM; Ariaans M; Spruijt L; van Essen T; Houge G; Schackert HK; Sheng JQ; Venselaar H; van Ravenswaaij-Arts CM; van Krieken JH; Hoogerbrugge N; Kuiper RP
    Gastroenterology; 2013 Sep; 145(3):544-7. PubMed ID: 23747338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer.
    Ye Y; Yang H; Grossman HB; Dinney C; Wu X; Gu J
    Cancer; 2008 Jun; 112(11):2467-74. PubMed ID: 18361427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ATM, CHEK2 and ERBB2 TAGSNPs and haplotypes on endometrial cancer risk.
    Einarsdóttir K; Humphreys K; Bonnard C; Li Y; Li Y; Chia KS; Liu ET; Hall P; Liu J; Wedrén S
    Hum Mol Genet; 2007 Jan; 16(2):154-64. PubMed ID: 17164260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
    Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
    Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional promoter polymorphism in the TERT gene does not affect inherited susceptibility to breast cancer.
    Varadi V; Brendle A; Grzybowska E; Johansson R; Enquist K; Butkiewicz D; Pamula-Pilat J; Pekala W; Hemminki K; Lenner P; Försti A
    Cancer Genet Cytogenet; 2009 Apr; 190(2):71-4. PubMed ID: 19380022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of TTK mutations in microsatellite-unstable colorectal cancer and evaluation of their effect on spindle assembly checkpoint.
    Niittymäki I; Gylfe A; Laine L; Laakso M; Lehtonen HJ; Kondelin J; Tolvanen J; Nousiainen K; Pouwels J; Järvinen H; Nuorva K; Mecklin JP; Mäkinen M; Ristimäki A; Ørntoft TF; Hautaniemi S; Karhu A; Kallio MJ; Aaltonen LA
    Carcinogenesis; 2011 Mar; 32(3):305-11. PubMed ID: 21163887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variants in epigenetic genes and breast cancer risk.
    Cebrian A; Pharoah PD; Ahmed S; Ropero S; Fraga MF; Smith PL; Conroy D; Luben R; Perkins B; Easton DF; Dunning AM; Esteller M; Ponder BA
    Carcinogenesis; 2006 Aug; 27(8):1661-9. PubMed ID: 16501248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single nucleotide polymorphisms in chromosomal instability genes and risk and clinical outcome of breast cancer: a Swedish prospective case-control study.
    Brendle A; Brandt A; Johansson R; Enquist K; Hallmans G; Hemminki K; Lenner P; Försti A
    Eur J Cancer; 2009 Feb; 45(3):435-42. PubMed ID: 19008095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
    Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
    Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk.
    Lee KM; Choi JY; Park SK; Chung HW; Ahn B; Yoo KY; Han W; Noh DY; Ahn SH; Kim H; Wei Q; Kang D
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):821-5. PubMed ID: 15824150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.